Since FAK is implicated in the angiogenesis process and induces the expression of VEGF, it was of interest to evaluate whether CTCs from breast cancer patients have activated the angiogenesis pathway by expressing HIF-1α and VEGF. The gene discussed is PTK2; the disease is breast carcinoma.